Cargando…
Tortuosity-powered microfluidic device for assessment of thrombosis and antithrombotic therapy in whole blood
Accurate assessment of blood thrombosis and antithrombotic therapy is essential for the management of patients in a variety of clinical conditions, including surgery and on extracorporeal life support. However, current monitoring devices do not measure the effects of hemodynamic forces that contribu...
Autores principales: | Luna, David J., R. Pandian, Navaneeth K., Mathur, Tanmay, Bui, Justin, Gadangi, Pranav, Kostousov, Vadim V., Hui, Shiu-Ki Rocky, Teruya, Jun, Jain, Abhishek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113244/ https://www.ncbi.nlm.nih.gov/pubmed/32238835 http://dx.doi.org/10.1038/s41598-020-62768-4 |
Ejemplares similares
-
Microengineered Human Vein-Chip Recreates Venous Valve Architecture and its Contribution to COVID-19-induced Thrombosis
por: Rajeeva Pandian, Navaneeth Krishna, et al.
Publicado: (2022) -
Is it time to switch to bivalirudin for ECMO anticoagulation?
por: Navaei, Amir, et al.
Publicado: (2023) -
Novel Coagulation Test Detects Anticoagulation Resistance and Is Associated With Thrombotic Events in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation
por: Frydman, Galit H., et al.
Publicado: (2022) -
Relationship between coronary tortuosity and plateletcrit coronary tortuosity and plateletcrit
por: Levent, Cerit, et al.
Publicado: (2017) -
Tripartite collaboration of blood‐derived endothelial cells, next generation RNA sequencing and bioengineered vessel‐chip may distinguish vasculopathy and thrombosis among sickle cell disease patients
por: Mathur, Tanmay, et al.
Publicado: (2021)